Resonance shared a post on LinkedIn:
“Join us next Friday, September 5th (9 AM ET) at ALRCaN!
Dr. Nirali N. Shah of the National Cancer Institute will share:
‘Dual-antigen targeting CART-cells: Is Two really better than One?’
We look forward to a great discussion.
Join us here.”
More posts featuring Resonance.